2.4.1.175: glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase This is an abbreviated version! For detailed information about glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase, go to the full flat file .
Reaction
UDP-N-acetyl-alpha-D-galactosamine +
[protein]-3-O-(beta-D-GlcA-(1->3)-beta-D-GalNAc-(1->4)-beta-D-GlcA-(1->3)-beta-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Xyl)-L-serine =
UDP +
[protein]-3-O-(beta-D-GalNAc-(1->4)-beta-D-GlcA-(1->3)-beta-D-GalNAc-(1->4)-beta-D-GlcA-(1->3)-beta-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Xyl)-L-serine
Synonyms AcbD, acetylgalactosaminyltransferase, uridine diphosphoacetylgalactosamine-chondroitin, II, ApCS, bifunctional CS synthase, ChGn-1, ChGn-2, chondroitin galactosaminyltransferase, chondroitin N-acetylgalactosaminyltransferase-1, chondroitin N-acetylgalactosaminyltransferase-2, chondroitin polymerase, chondroitin sulfate beta-1,4-N-acetylgalactosaminyltransferase-1, chondroitin sulfate glucuronyltransferase, chondroitin sulfate glycosyltransferase, chondroitin sulfate N-acetylgalactosaminyltransferase-1, chondroitin sulfate N-acetylgalactosaminyltransferase-2, chondroitin sulfate synthase 1, chondroitin sulfate synthase-1, chondroitin sulfate synthase-2, chondroitin sulfate synthase-2/chondroitin polymerizing factor, chondroitin sulfate synthase-3, chondroitin synthase, chondroitin synthase 1, chondroitin synthase-1, chondroitin synthase-2, chondroitin synthase-3, CHPF, ChSy, ChSy-1, ChSy-2, ChSy-3, CHSY1, CpCS, Cpha266_2341, CS glycosyltransferase, CS N-acetylgalactosaminyltransferase-1, CS synthase 1, CS synthase-1, CSGalNAcT-2, CSGlcA-T, CSS1, CSS2, CSS3, GalNAc-T, glucuronyl-N-acetylgalactosaminylproteoglycan beta1,4-N-acetylgalactosaminyltransferase, K4CP, More, N-acetylgalactosaminyltransferase II, UDP-N-acetyl-D-galactosamine:D-glucuronyl-N-acetyl-1,3-beta-D-galactosaminylproteoglycan beta-1,4-N-acetylgalactosaminyltransferase, uridine diphosphoacetylgalactosamine-chondroitin acetylgalactosaminyltransferasec II
ECTree
Source Tissue
Source Tissue on EC 2.4.1.175 - glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
-
brenda
-
-
brenda
-
-
brenda
-
brenda
-
-
brenda
-
-
brenda
-
brenda
low-grade
brenda
melanoma cell line
brenda
-
brenda
CHSY1 is frequently upregulated in glioblastoma and correlates with high tumor grade and poor survival
brenda
-
brenda
-
brenda
-
-
brenda
-
brenda
-
brenda
-
-
brenda
-
brenda
malignant
brenda
-
-
brenda
-
brenda
thyroid cancer cell line
brenda
-
brenda
myeloma cell line
brenda
low content
brenda
very low expression level
brenda
ASMC
brenda
ASMC
brenda
-
ASMC
-
brenda
-
brenda
very low expression level
brenda
-
brenda
-
brenda
-
brenda
-
-
brenda
-
brenda
-
-
brenda
-
-
-
brenda
-
brenda
-
brenda
-
-
brenda
-
brenda
in nontumorous cartilages
brenda
-
-
brenda
-
brenda
-
brenda
low content
brenda
very low expression level
brenda
-
-
brenda
-
embryonic, expression level analysis for the splice variants CSS2A and CSS2B, overview
brenda
-
embryonic, expression level analysis for the splice variants CSS2A and CSS2B, overview
-
brenda
-
brenda
-
brenda
-
brenda
-
-
brenda
-
brenda
-
-
brenda
-
brenda
-
brenda
-
brenda
-
brenda
very low content
brenda
very low expression level
brenda
-
-
brenda
-
brenda
from peripheral blood
brenda
from peripheral blood
brenda
peripheral blood
brenda
peripheral blood
brenda
low content
brenda
high content
brenda
very low expression level
brenda
-
brenda
-
brenda
-
brenda
-
brenda
very low content
brenda
-
-
brenda
-
brenda
-
brenda
-
brenda
-
-
brenda
-
brenda
low content
brenda
high content
brenda
-
-
brenda
-
brenda
-
brenda
-
brenda
-
brenda
-
brenda
-
brenda
-
brenda
-
brenda
-
brenda
very high content
brenda
very high content
brenda
very low expression level
brenda
soft tissue sarcomas with myxoid substance: myxoid liposarcoma, 14 of myxofibrosarcoma, 12 of malignant peripheral nerve sheath tumor, and 2 of low-grade fibromyxoid sarcoma. Soft tissue sarcoma is a malignant tumor of nonepithelial extraskeletal origin classified by specific, differentiated cell types
brenda
soft tissue sarcomas. Soft tissue sarcoma is a malignant tumor of nonepithelial extraskeletal origin classified by specific, differentiated cell types
brenda
-
-
brenda
-
-
brenda
-
brenda
-
brenda
-
brenda
-
brenda
-
-
brenda
-
brenda
-
brenda
-
brenda
-
-
brenda
-
brenda
high content
brenda
-
-
brenda
-
brenda
-
brenda
-
brenda
high content
brenda
-
-
brenda
-
brenda
low content
brenda
-
brenda
-
brenda
-
brenda
low content
brenda
very low expression level
brenda
high content
brenda
very high content
brenda
very low expression level
brenda
-
brenda
-
brenda
vascular wall
brenda
vascular wall
brenda
-
vascular wall
-
brenda
additional information
enzyme CHSY1 is strongly expressed in myxofibrosarcoma and malignant peripheral nerve sheath tumor compared with other tumors and significantly associated with higher rather than lower grade tumors, mmunohistochemic analysis, overview
brenda
additional information
ChGn-2 expression on early and advanced atherosclerotic lesions, overview
brenda
additional information
CHSY1 is strongly expressed in myxofibrosarcoma and malignant peripheral nerve sheath tumor compared with other tumors and significantly associated with higher, rather than lower-grade tumors. High expression of CHSY1 is also significantly associated with poorer patient outcomes and higher stages, overview. Enzyme CHSY1 expression correlates with malignant potential of soft tissue sarcomas with myxoid substance. Immunohistochemical analysis of CHSY1 in soft tissue sarcomas with myxoid substance
brenda
additional information
-
the enzyme is expressed (at very low levels) in the prehypertrophic zone of the growth plate at E16.5, colocalized with aggrecan core protein.
brenda
additional information
-
CSS2 quantitative tissue expression analysis by realtime RT-PCR, overview
brenda